HED-2TNCT07821294
Feasibility and Performance of FFPE qPCR for Detection of Clarithromycin Resistance in Helicobacter Pylori
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Recruitment opened
- Start date changed from estimate of Sep 1, 2026 to Sep 10, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Diagnostic performance of q-PCR on FFPE gastric biopsies for detection of Helicobacter pylori clarithromycin resistance
Timeframe: Within 10 days after gastric biopsy collection
Secondary (5)
Prevalence of clarithromycin resistance in Helicobacter pylori infection
Concordance between q-PCR FFPE and immunohistochemistry results
Concordance between q-PCR FFPE and bacteriological PCR results
Impact of q-PCR results on therapeutic management
Medical-economic impact of q-PCR FFPE strategy
Arms and interventions
Diagnostic tests: q-PCR on FFPE gastric biopsies
Sites
1 site in 1 country
- BenkessouParis, France